LifeStance Health (LFST) director receives 45,495-share stock award

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Kenneth A. Burdick reported an equity award under which he acquired 45,495 shares of common stock at $0.0000 per share, characterized as a grant or award acquisition. Following this award, he reports 3,470,810 shares held directly and 46,511 shares held indirectly through Burdick Family LLC. His reported holdings include 45,495 restricted stock units, each representing a contingent right to receive one share of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Burdick Kenneth A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	45,495	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,470,810 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (1)

1. [object Object]

Key Figures

Awarded shares: 45,495 shares Award price: $0.0000 per share Direct holdings after award: 3,470,810 shares +2 more

5 metrics

Awarded shares 45,495 shares Grant, award, or other acquisition of common stock on 2026-07-06

Award price $0.0000 per share Price per share for the 45,495-share equity grant

Direct holdings after award 3,470,810 shares Common shares held directly by Kenneth A. Burdick after the reported transactions

Indirect holdings 46,511 shares Common shares held indirectly through Burdick Family LLC after the reported transactions

Restricted stock units 45,495 RSUs Restricted stock units included in reported holdings; each RSU is a right to one share

Key Terms

restricted stock units, contingent right, indirect

3 terms

restricted stock units financial

"Includes 45,495 restricted stock units (RSUs)."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share."

indirect financial

"46,511 shares held indirectly through Burdick Family LLC."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/14/2026 - 06:12 PM Accepted by SEC EDGAR 07/14/2026 - 06:12 PM Learn about SEC filing dates

FAQ

What insider transaction did LifeStance Health Group (LFST) director Kenneth Burdick report?

Kenneth A. Burdick reported receiving an equity grant of 45,495 shares of LifeStance common stock at $0.0000 per share. After this grant, he reports holding 3,470,810 shares directly and 46,511 shares indirectly through Burdick Family LLC.

How many LifeStance (LFST) shares does Kenneth Burdick now hold directly and indirectly?

Following the reported grant, Kenneth Burdick holds 3,470,810 LifeStance common shares directly. He also reports 46,511 shares held indirectly through Burdick Family LLC, reflecting his total reported ownership after the Form 4 transactions.

What do the 45,495 restricted stock units (RSUs) in LifeStance (LFST) mean?

The filing notes that Burdick’s reported holdings include 45,495 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of LifeStance common stock, rather than an already-issued share.

Was Kenneth Burdick’s LifeStance (LFST) Form 4 a market purchase or sale?

The Form 4 reports an equity grant coded as a grant, award, or other acquisition of 45,495 shares at $0.0000 per share. This indicates a compensation-related award, not an open-market purchase or sale transaction.

Who holds the indirect LifeStance (LFST) shares associated with Kenneth Burdick?

The Form 4 shows 46,511 LifeStance common shares held indirectly through Burdick Family LLC. These shares are reported as indirect ownership, distinguishing them from Burdick’s directly held 3,470,810-share position.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/06/2026		A		45,495(1)	A	$0.00	3,470,810	D
Common Stock								46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 45,495 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	By: /s/ Ryan Pardo, Attorney-in-Fact	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)